162 related articles for article (PubMed ID: 29888231)
1. Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.
Vawter MP; Philibert R; Rollins B; Ruppel PL; Osborn TW
Mol Neuropsychiatry; 2018 May; 3(4):197-213. PubMed ID: 29888231
[TBL] [Abstract][Full Text] [Related]
2. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
3. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
4. Shared gene expression alterations in schizophrenia and bipolar disorder.
Shao L; Vawter MP
Biol Psychiatry; 2008 Jul; 64(2):89-97. PubMed ID: 18191109
[TBL] [Abstract][Full Text] [Related]
5. Verbal episodic memory along the course of schizophrenia and bipolar disorder: a new perspective.
Czepielewski LS; Massuda R; Goi P; Sulzbach-Vianna M; Reckziegel R; Costanzi M; Kapczinski F; Rosa AR; Gama CS
Eur Neuropsychopharmacol; 2015 Feb; 25(2):169-75. PubMed ID: 25311898
[TBL] [Abstract][Full Text] [Related]
6. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
Girshkin L; Matheson SL; Shepherd AM; Green MJ
Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
[TBL] [Abstract][Full Text] [Related]
7. The impact of familial risk for schizophrenia or bipolar disorder on cognitive control during episodic memory retrieval.
Christodoulou T; Messinis L; Papathanasopoulos P; Frangou S
Psychiatry Res; 2012 May; 197(3):212-6. PubMed ID: 22417935
[TBL] [Abstract][Full Text] [Related]
8. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging-aided differential diagnosis of the depressive state.
Takizawa R; Fukuda M; Kawasaki S; Kasai K; Mimura M; Pu S; Noda T; Niwa S; Okazaki Y;
Neuroimage; 2014 Jan; 85 Pt 1():498-507. PubMed ID: 23764293
[TBL] [Abstract][Full Text] [Related]
10. Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder.
Solís-Chagoyán H; Calixto E; Figueroa A; Montaño LM; Berlanga C; Rodríguez-Verdugo MS; Romo F; Jiménez M; Gurrola CZ; Riquelme A; Benítez-King G
Schizophr Res; 2013 Feb; 143(2-3):384-9. PubMed ID: 23290267
[TBL] [Abstract][Full Text] [Related]
11. Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.
Fond G; Boyer L; Gaman A; Laouamri H; Attiba D; Richard JR; Delavest M; Houenou J; Le Corvoisier P; Charron D; Krishnamoorthy R; Oliveira J; Tamouza R; Yolken R; Dickerson F; Leboyer M; Hamdani N
J Psychiatr Res; 2015 Apr; 63():58-64. PubMed ID: 25769398
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters.
Rive MM; Redlich R; Schmaal L; Marquand AF; Dannlowski U; Grotegerd D; Veltman DJ; Schene AH; Ruhé HG
Bipolar Disord; 2016 Nov; 18(7):612-623. PubMed ID: 27870505
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.
Rollins BL; Morgan L; Hjelm BE; Sequeira A; Schatzberg AF; Barchas JD; Lee FS; Myers RM; Watson SJ; Akil H; Potkin SG; Bunney WE; Vawter MP
Mol Neuropsychiatry; 2018 Feb; 3(3):157-169. PubMed ID: 29594135
[TBL] [Abstract][Full Text] [Related]
14. Basal ganglia volumetric changes in psychotic spectrum disorders.
Liu C; Cao B; Yu R; Sim K
J Affect Disord; 2019 Aug; 255():150-157. PubMed ID: 31153051
[TBL] [Abstract][Full Text] [Related]
15. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
16. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition.
Chun J; Karam ZN; Marzinzik F; Kamali M; O'Donnell L; Tso IF; Manschreck TC; McInnis M; Deldin PJ
Schizophr Res; 2013 Dec; 151(1-3):175-84. PubMed ID: 24210871
[TBL] [Abstract][Full Text] [Related]
17. Neurological and cerebellar soft signs do not discriminate schizophrenia from bipolar disorder patients.
Chrobak AA; Siwek GP; Siuda-Krzywicka K; Arciszewska A; Starowicz-Filip A; Siwek M; Dudek D
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():96-101. PubMed ID: 26241859
[TBL] [Abstract][Full Text] [Related]
18. Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response.
Singh A; Shannon CP; Kim YW; Yang CX; Balshaw R; Cohen Freue GV; Gauvreau GM; FitzGerald JM; Boulet LP; O'Byrne PM; Tebbutt SJ
Am J Respir Crit Care Med; 2018 Feb; 197(4):450-462. PubMed ID: 29087730
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia.
Li C; Tao H; Yang X; Zhang X; Liu Y; Tang Y; Tang A
Int J Med Sci; 2018; 15(9):900-906. PubMed ID: 30008602
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
